These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9134072)

  • 21. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
    Lott DC; Strain EC; Brooner RK; Bigelow GE; Johnson RE
    J Subst Abuse Treat; 2006 Sep; 31(2):187-94. PubMed ID: 16919747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of one-day vs. three-day buprenorphine inpatient detoxification protocols for heroin dependence.
    Hopper JA; Wu J; Martus W; Pierre JD
    J Opioid Manag; 2005; 1(1):31-5. PubMed ID: 17315409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.
    Giacomuzzi SM; Ertl M; Kemmler G; Riemer Y; Vigl A
    ScientificWorldJournal; 2005 May; 5():452-68. PubMed ID: 15925962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices.
    Greenwald M; Johanson CE; Bueller J; Chang Y; Moody DE; Kilbourn M; Koeppe R; Zubieta JK
    Biol Psychiatry; 2007 Jan; 61(1):101-10. PubMed ID: 16950210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification.
    Preston KL; Bigelow GE; Liebson IA
    Clin Pharmacol Ther; 1985 Aug; 38(2):219-27. PubMed ID: 2410178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions.
    Breen CL; Harris SJ; Lintzeris N; Mattick RP; Hawken L; Bell J; Ritter AJ; Lenné M; Mendoza E
    Drug Alcohol Depend; 2003 Jul; 71(1):49-55. PubMed ID: 12821205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early experience with Suboxone maintenance therapy in Hungary.
    Demetrovics Z; Farkas J; Csorba J; Németh A; Mervó B; Szemelyácz J; Fleischmann E; Kassai-Farkas A; Petke Z; Oroján T; Rózsa S; Rigó P; Funk S; Kapitány M; Kollár A; Rácz J
    Neuropsychopharmacol Hung; 2009 Dec; 11(4):249-57. PubMed ID: 20150662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid heroin detoxification using a single high dose of buprenorphine.
    Kutz I; Reznik V
    J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Buprenorphine and methadone to opiate addicts--a randomized trial].
    Kristensen Ø; Espegren O; Asland R; Jakobsen E; Lie Ø; Seiler S
    Tidsskr Nor Laegeforen; 2005 Jan; 125(2):148-51. PubMed ID: 15665884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
    Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
    Gerra G; Zaimovic A; Rustichelli P; Fontanesi B; Zambelli U; Timpano M; Bocchi C; Delsignore R
    J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids.
    Mutschler NH; Stephen BJ; Teoh SK; Mendelson JH; Mello NK
    Nicotine Tob Res; 2002 May; 4(2):223-8. PubMed ID: 12028854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of buprenorphine and methadone in methadone-maintained subjects.
    Walsh SL; June HL; Schuh KJ; Preston KL; Bigelow GE; Stitzer ML
    Psychopharmacology (Berl); 1995 Jun; 119(3):268-76. PubMed ID: 7675960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hair analysis for long-term monitoring of buprenorphine intake in opiate withdrawal.
    Pirro V; Fusari I; Di Corcia D; Gerace E; De Vivo E; Salomone A; Vincenti M
    Ther Drug Monit; 2014 Dec; 36(6):796-807. PubMed ID: 24713865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients.
    Eissenberg T; Johnson RE; Bigelow GE; Walsh SL; Liebson IA; Strain EC; Stitzer ML
    Drug Alcohol Depend; 1997 Apr; 45(1-2):81-91. PubMed ID: 9179510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [High-dose methadone detoxification in a hospital unit. Clinical experience].
    Ochoa E; Salvador E; Madoz-Gúrpide A; Lázaro M
    Adicciones; 2008; 20(3):245-9. PubMed ID: 18813771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.